Business Wire

Forecasting, Monitoring and KI – Swarm Intelligence for the Energy Transition at EM-Power Europe

1.6.2023 12:26:00 EEST | Business Wire | Press release

Share

The energy transition does not just change the energy generation technologies we use, but also requires the power grids to be updated. Today, instead of a dozen large-scale power plants, an enormous swarm of power plants all feed into our grid: Several thousand wind farms and over 2.6 million PV systems have been installed in Germany alone – and there is a steep upward trend. This makes our power generation weather dependent: On windless or cloudy days, the energy supply may not match the demand, leading to bottlenecks – or worse – blackouts. To keep the grid frequency at a stable 50.2 hertz, grid operators need yield forecasts. Artificial intelligence (AI) helps process this highly complex information and integrate it into the energy system.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230601005572/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

EM-Power Europe Exhibition (Photo: Solar Promotion GmbH)

With millions of solar installations, wallboxes and heat pumps, home storage systems and car batteries that will someday be able to feed electricity back into the grid, today’s utility grid system is already so complex that utilities and grid operators would be lost without their digitalized systems. The more they know about when, where and how much electricity is being produced, fed into the grid and demanded by consumers, the more precisely can they match their supply to the demand. This also makes it more profitable, as making up for shortages is expensive. When generation does not cover consumption within a balancing group, grid operators are forced to pay balancing costs. The more accurate the weather and yield forecasts for wind and solar power plants, the more successful the companies will be. Individuals who want to optimize their self-consumption using batteries or controllable consumers like e-cars or heat pumps also require forecasts to determine what the electricity should be used for. The same goes for the energy management of buildings.

Weather forecast for the energy industry

At EM-Power Europe, the international exhibition for energy management and integrated energy solutions, companies from all around the world present their digitalization concepts as well as innovative technologies and services for the optimized grid of the future. “Machine learning and AI play a crucial role in the irradiation forecast,” Jan Remund, Head of the Department for Energy and Climate at Meteotest AG, a Swiss weather forecast provider, explains. The company is able to predict cloud movements by combining physical models with self-learning algorithms based on satellite images. “The accuracy for the next few hours is quite high. The longer the time span, the less accurate the forecasts are,” says Remund. His company collects irradiation and temperature data and uses it to make analyses, profiles and forecasts that can be integrated into the respective PV monitoring or control software. Companies can use the weather forecasts as a basis for calculating solar irradiation using dedicated software, or they can buy such calculations. Grid operators rely on irradiation forecasts to balance the grid’s feed-in and feed-out based on the production and demand forecasts.

Meteocontrol, a monitoring and forecast specialist company from the South of Germany makes yield calculations based on the data of different weather forecast providers. The company also investigates how aerosols like ash or sand affect cloud formation. “On March 3 and 4, 2021, our research project “PermaStrom” exemplified how important this issue is,” says Stijn Stevens, CEO of meteocontrol. “There was a lot of Saharan dust in Europe on those two days. Thanks to optimized forecasts, about three million euros were saved in balancing energy costs in Germany alone.

The integration of smart applications and AI into the utility grid system creates digital swarm intelligence. By combining the power generation and consumption forecasts with the capacity of conventional power plants, grid operators can predict when and where the grids and transformers will reach their maximum capacity. This allows them to take the necessary precautions.

Prosumers: underestimated key players

Prosumers will play a vital role in the energy systems of the future: For instance, private individuals and households can feed excess electricity from their e-cars into the grid, contributing significantly to its stability. The company Hive Power already offers software for the intermittent feedback of electricity from car batteries into the grid, called Vehicle-to-Grid. Artificial intelligence helps here, too: The software learns when vehicles are in use and when they are not, allowing it to feed electricity into the grid when there is excess capacity. Prosumers could earn up to 1,000 euros per year in this way.

Smart technology for buildings

Weather and yield forecasts are also crucial for the energy management of buildings. Heat pumps can charge the heating storage device when the sun is shining, and feed the energy into the heating circuit in the evening. With the right software, heat pumps can apply the yield forecasts provided by the energy management system to their operating schedules. This prevents heat pumps from using grid-supplied electricity to heat thermal energy storage when sufficient solar energy is expected within the next hour. Another possibility is to time the charging of electric vehicles in a way that maximizes the share of solar power. Solar-Log’s systems are based on the same principle. They provide optimal electricity self-consumption for office buildings and industrial facilities through battery storage and flexible loads, such as heat pumps or charging stations.

Apart from the aforementioned companies, numerous other exhibitors will present their solutions for weather and yield forecasts, grid connection, monitoring and analysis software at EM-Power Europe in Munich from June 14–16. Visitors can learn more about the possibilities of forecasting and monitoring systems at the EM-Power Forum session “Forecasting & monitoring: Always a step ahead” (“Forecasting & Monitoring: Immer einen Schritt voraus sein”).

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Press Contacts

Peggy Zilay
Spokesperson
The smarter E Europe
+49 7231 58598-240
zilay@solarpromotion.com

Juliane Heermeier
Account Manager
+49 151 41482446
juliane.heermeier@fischerappelt.de

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 17:18:00 EEST | Press release

Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522186975/en/ Adam Plich, CEO and Co-Founder of Avanzanite Bioscience. “Thalassaemia is a complex, chronic and multisystem disease characterised by anaemia, ineffective erythropoiesis and haemo

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 15:30:00 EEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu ® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 15:00:00 EEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 14:45:00 EEST | Press release

Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, signalling a shift in health systems from late-stage treatment to earlier intervention. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522587414/en/ Selected from 393 submissions across 68 countries, the winning teams were recognised through the inaugural ‘Future Health Challenge 2026: Building Anticipatory Health Systems through Population Sensing’, delivered by Future Health – A Global Initiative by Abu Dhabi in collaboration with MIT Solve. Health systems globally are facing rising costs and persistent delays in diagnosis, with many conditions still identified only after symptoms become severe. At the sam

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye